Phylodynamic analysis of SARS-CoV-2 spread in Rio de Janeiro, Brazil, highlights how metropolitan areas act as dispersal hubs for new variants
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
During the first semester of 2021, all of Brazil has suffered an intense wave of COVID-19 associated with the Gamma variant. In July, the first cases of Delta variant were detected in the state of Rio de Janeiro. In this work, we have employed phylodynamic methods to analyse more than 1 600 genomic sequences of Delta variant collected until September in Rio de Janeiro to reconstruct how this variant has surpassed Gamma and dispersed throughout the state. After the introduction of Delta, it has initially spread mostly in the homonymous city of Rio de Janeiro, the most populous of the state. In a second stage, dispersal occurred to mid- and long-range cities, which acted as new close-range hubs for spread. We observed that the substitution of Gamma by Delta was possibly caused by its higher viral load, a proxy for transmissibility. This variant turnover prompted a new surge in cases, but with lower lethality than was observed during the peak caused by Gamma. We reason that high vaccination rates in the state of Rio de Janeiro were possibly what prevented a higher number of deaths.
Article activity feed
-
-
SciScore for 10.1101/2022.01.17.22269136: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Epidemiological analyses: Daily number of confirmed COVID-19 cases, deaths and people vaccinated were obtained from the National Immunization Program (Programa Nacional de Imunização, PNI), esus-VE and SIVEP-Gripe databases through the COVID-19 portal (https://www.saude.rj.gov.br/informacao-sus/dados-sus/2020/11/covid-19) maintained by the Secretary of Health of the state of Rio de Janeiro. National Immunization Programsuggested: (Centers for Disease Control and Prevention, RRID:SCR_012976)All newly sequenced and assembled genomes are publicly available at GISAID (Table S1) and SRA-NCBI … SciScore for 10.1101/2022.01.17.22269136: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Epidemiological analyses: Daily number of confirmed COVID-19 cases, deaths and people vaccinated were obtained from the National Immunization Program (Programa Nacional de Imunização, PNI), esus-VE and SIVEP-Gripe databases through the COVID-19 portal (https://www.saude.rj.gov.br/informacao-sus/dados-sus/2020/11/covid-19) maintained by the Secretary of Health of the state of Rio de Janeiro. National Immunization Programsuggested: (Centers for Disease Control and Prevention, RRID:SCR_012976)All newly sequenced and assembled genomes are publicly available at GISAID (Table S1) and SRA-NCBI (BioProject PRJNA774631) databases.. BioProjectsuggested: (NCBI BioProject, RRID:SCR_004801)These sequences were independently aligned to the WH01 (EPI ISL 406798) sequence from Wuhan, China using MAFFT v. MAFFTsuggested: (MAFFT, RRID:SCR_011811)The outgroup (WH01) was then removed and root-to-tip distances were calculated using TempEst. TempEstsuggested: (TempEst, RRID:SCR_017304)To accomplish this, we used the BEAST software and the Relaxed Random Walk model with Cauchy’s distribution on coordinates randomly selected within each sample’s collection city. BEASTsuggested: (BEAST, RRID:SCR_010228)Dispersal routes were extracted from the consensus tree using the seraphim package and plotted using the ggplot2 package, both in R software. ggplot2suggested: (ggplot2, RRID:SCR_014601)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-